The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion

Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequen...

Full description

Bibliographic Details
Main Authors: Aman Upadhyay, Kate E. Boyle, Tom L. Broderick
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/22/6872
_version_ 1797509172882833408
author Aman Upadhyay
Kate E. Boyle
Tom L. Broderick
author_facet Aman Upadhyay
Kate E. Boyle
Tom L. Broderick
author_sort Aman Upadhyay
collection DOAJ
description Carnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequences of type 1 diabetes, including hypoinsulinemia, hyperglycemia, and increased urine output. Systemic hypocarnitinemia, expressed as free carnitine levels, was evident in the plasma, liver, and kidney of diabetic rats. Compared to control rats, the low free carnitine in the plasma of diabetic rats was accompanied by decreased expression of γ-butyrobetaine hydroxylase in liver and kidney, suggesting impaired carnitine biosynthesis. Expression of organic cation transporter-2 in kidney was also reduced, indicating impaired renal reabsorption, and confirmed by the presence of elevated levels of free carnitine in the urine of diabetic rats. Insulin treatment of diabetic rats reversed the plasma hypocarnitinemia, increased the free carnitine content in both kidney and liver, and prevented urinary losses of free carnitine. This was associated with increased expression of γ-butyrobetaine hydroxylase and organic cation transporter-2. The results of our study indicate that type 1 diabetes induced with streptozotocin disrupts carnitine biosynthesis and renal uptake mechanisms, leading to carnitine insufficiency. These aberrations in carnitine homeostasis are prevented with daily insulin treatment.
first_indexed 2024-03-10T05:14:14Z
format Article
id doaj.art-aadbde9767c846b08b8b2a0e8cf5e801
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T05:14:14Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-aadbde9767c846b08b8b2a0e8cf5e8012023-11-23T00:35:01ZengMDPI AGMolecules1420-30492021-11-012622687210.3390/molecules26226872The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal ExcretionAman Upadhyay0Kate E. Boyle1Tom L. Broderick2Department of Biomedical Sciences, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USAArizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ 85308, USALaboratory of Diabetes and Exercise Metabolism, Department of Physiology, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USACarnitine insufficiency is reported in type 1 diabetes mellitus. To determine whether this is accompanied by defects in biosynthesis and/or renal uptake, liver and kidney were obtained from male Sprague-Dawley rats with streptozotocin-induced diabetes. Diabetic rats exhibited the metabolic consequences of type 1 diabetes, including hypoinsulinemia, hyperglycemia, and increased urine output. Systemic hypocarnitinemia, expressed as free carnitine levels, was evident in the plasma, liver, and kidney of diabetic rats. Compared to control rats, the low free carnitine in the plasma of diabetic rats was accompanied by decreased expression of γ-butyrobetaine hydroxylase in liver and kidney, suggesting impaired carnitine biosynthesis. Expression of organic cation transporter-2 in kidney was also reduced, indicating impaired renal reabsorption, and confirmed by the presence of elevated levels of free carnitine in the urine of diabetic rats. Insulin treatment of diabetic rats reversed the plasma hypocarnitinemia, increased the free carnitine content in both kidney and liver, and prevented urinary losses of free carnitine. This was associated with increased expression of γ-butyrobetaine hydroxylase and organic cation transporter-2. The results of our study indicate that type 1 diabetes induced with streptozotocin disrupts carnitine biosynthesis and renal uptake mechanisms, leading to carnitine insufficiency. These aberrations in carnitine homeostasis are prevented with daily insulin treatment.https://www.mdpi.com/1420-3049/26/22/6872diabetescarnitinebiosynthesisuptakekidneyurine
spellingShingle Aman Upadhyay
Kate E. Boyle
Tom L. Broderick
The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
Molecules
diabetes
carnitine
biosynthesis
uptake
kidney
urine
title The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_full The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_fullStr The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_full_unstemmed The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_short The Effects of Streptozotocin-Induced Diabetes and Insulin Treatment on Carnitine Biosynthesis and Renal Excretion
title_sort effects of streptozotocin induced diabetes and insulin treatment on carnitine biosynthesis and renal excretion
topic diabetes
carnitine
biosynthesis
uptake
kidney
urine
url https://www.mdpi.com/1420-3049/26/22/6872
work_keys_str_mv AT amanupadhyay theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT kateeboyle theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT tomlbroderick theeffectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT amanupadhyay effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT kateeboyle effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion
AT tomlbroderick effectsofstreptozotocininduceddiabetesandinsulintreatmentoncarnitinebiosynthesisandrenalexcretion